Atlas Trials

An 18-week Study to Evaluate a Test Product With a Marketed Prescription Product

Clinical trial NCT07136766 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07136766
Sponsor
Good Molecules, LLC
Status
ENROLLING_BY_INVITATION
Phase
Phase 3
Study type
INTERVENTIONAL
Hyperpigmentation
Start date
2025-09-10
Primary completion
2026-02-16
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.